全文获取类型
收费全文 | 1146篇 |
免费 | 31篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 27篇 |
妇产科学 | 1篇 |
基础医学 | 26篇 |
口腔科学 | 16篇 |
临床医学 | 107篇 |
内科学 | 57篇 |
皮肤病学 | 4篇 |
神经病学 | 57篇 |
特种医学 | 18篇 |
外科学 | 220篇 |
综合类 | 294篇 |
预防医学 | 48篇 |
药学 | 299篇 |
中国医学 | 9篇 |
肿瘤学 | 4篇 |
出版年
2024年 | 3篇 |
2023年 | 5篇 |
2022年 | 8篇 |
2021年 | 14篇 |
2020年 | 13篇 |
2019年 | 13篇 |
2018年 | 17篇 |
2017年 | 24篇 |
2016年 | 31篇 |
2015年 | 29篇 |
2014年 | 83篇 |
2013年 | 67篇 |
2012年 | 80篇 |
2011年 | 84篇 |
2010年 | 77篇 |
2009年 | 82篇 |
2008年 | 68篇 |
2007年 | 66篇 |
2006年 | 70篇 |
2005年 | 60篇 |
2004年 | 31篇 |
2003年 | 43篇 |
2002年 | 32篇 |
2001年 | 37篇 |
2000年 | 20篇 |
1999年 | 13篇 |
1998年 | 9篇 |
1997年 | 21篇 |
1996年 | 17篇 |
1995年 | 11篇 |
1994年 | 14篇 |
1993年 | 9篇 |
1992年 | 3篇 |
1991年 | 10篇 |
1990年 | 6篇 |
1989年 | 5篇 |
1988年 | 1篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
排序方式: 共有1192条查询结果,搜索用时 15 毫秒
1.
刘志刚 《中国小儿急救医学》2004,11(3):152-153
目的 以安定溶液直肠给药为对照 ,探讨咪达唑仑溶液鼻腔给药对惊厥急救的价值。方法 36例急性惊厥儿童对比观察鼻腔内滴入咪达唑仑与直肠内注入安定的疗效 ,开始治疗时间、用药后控制发作时间、自患儿到达医院至发作控制的总时间、对脑电活动的影响、在控制惊厥方面的疗效及副作用等指标。结果 咪达唑仑溶液鼻腔给药 ,自患儿到达医院至开始给药的平均时间为 32 8s、给药后至控制惊厥的平均时间为 15 6 8s、自患儿到达医院至惊厥控制时间为 189 6s ,都明显快于安定直肠给药组。且控制惊厥疗效好于安定组。二组通过监测心率、呼吸、血压均未发现任何副作用。结论 咪达唑仑溶液鼻腔给药是一种安全、更为快速、有效的治疗临床急性惊厥的方法 相似文献
2.
腹腔镜手术病人咪达唑仑-芬太尼-异丙酚麻醉诱导的优化配伍方案 总被引:3,自引:0,他引:3
目的 采用权重配方法探讨腹腔镜手术病人咪达唑仑、芬太尼、异丙酚复合麻醉诱导的优化配伍方案。方法选择ASAⅠ或Ⅱ级择期腹腔镜手术病人60例,男34例,女26例,年龄31~55岁。诱导药物的低效量和足量分别确定为咪达唑仑0.02、0.06mg/kg,芬太尼2、6μg/kg,异丙酚0.5、1.5mg/kg。根据权重配方法,将病人随机分配至3种药物不同剂量组合的6个配伍组(n=10)。连续监测脑电双频谱指数(BIS)、心率(HR)、平均动脉压(MAP)、脉搏血氧饱和度(SpO2)。各组依次静脉注射相应剂量咪达唑仑、芬太尼、异丙酚和罗库溴铵0.6mg/kg行麻醉诱导和气管插管。记录诱导前即刻、异丙酚注入后1、2min、插管即刻、插管后1、3、5、7min的BIS、MAP及HR。按权重配方法的剂量优化原则评判复合药效,分析各组份药的重要程度及相互作用的性质。结果以BIS为评价指标,当咪达唑仑0.06mg/kg、芬太尼5μg/ks、异丙酚1.0mg/kg配伍时,异丙酚为主药,异丙酚与咪达唑仑和芬太。尼具有相加性作用;以MAP为评价指标,当咪达唑仑0.06mg/kg、芬太尼5μg,kg、异丙酚1.5mg/kg配伍时,异丙酚为主药,异丙酚与咪达唑仑具有协同性作用,异丙酚与芬太尼具有相加性作用;以HR为评价指标,当咪达唑仑0.06mg/kg、芬太尼5μg/kg、异丙酚1.0mg/kg配伍时,芬太尼为主药,异丙酚与咪达唑仑和芬太尼具有协同性作用。结论腹腔镜手术病人咪达唑仑、芬太尼、异丙酚复合麻醉诱导在维持镇静方面为相加作用,在维持血液动力学稳定方面为协同作用;优化配伍方案为咪达唑仑0.06mg/kg、芬太尼5μg/kg、异丙酚1.5mg/kg。 相似文献
3.
目的观察低位硬膜外麻醉下肛肠手术辅用力月西和丙泊酚的镇静和遗忘作用。方法对66例患者随机分为A、B两组,分别辅用力月西和丙泊酚,观察镇静和遗忘作用及血压、心率和呼吸变化。结果两组镇静评估的比较无显著性差异(P﹤0.05);遗忘率不同,B组患者遗忘率低于A组。结论丙泊酚和力月西辅用于低位硬膜外麻醉下肛肠外科手术,都达到了良好的镇静作用,力月西更具有良好的顺行性遗忘作用。 相似文献
4.
目的 探讨在十二指肠乳头括约肌切开 (EST)胆总管取石术前静注咪唑安定的可行性及价值。方法 将 71例拟行 EST胆总管取石患者随机分为咪唑安定组 (试验组 ) 5 1例和对照组 (2 0例 ) ,两组术前均给予 6 5 4 -2 (10 mg)静脉注射 ,试验组同时静脉注射咪唑安定 (3~ 5 mg)。观察两组患者的进镜时间、麻醉程度 ,患者的反应与配合程度、自身感受程度 ,同时监测患者的血压、心率、血氧饱和度。结果 试验组进镜时间缩短、镇静程度适中、患者自身感受好 ,与对照组比较 ,差异有显著性 (P<0 .0 1) ;患者心血管及呼吸参数无明显变化。结论 EST胆总管取石术前静脉注射咪唑安定可提高麻醉效果 ,有利于提高患者配合的依从性 ,对血压、心率、血氧饱和度无明显影响 相似文献
5.
丙泊酚、氯胺酮全凭静脉麻醉应用于烧伤病人的临床研究 总被引:1,自引:1,他引:0
目的:研究微量注射泵输注丙泊酚和氯胺酮全凭静脉麻醉在烧伤患者切痂植皮手术中的临床效果。方法:选择期手术患者,随机分为丙泊酚、氯胺酮组(P·K组)和咪达唑仑、氯胺酮组(M·K组)。P·K组术前10min首次静注丙泊酚2mg·kg和氯胺酮2mg·kg。M·K组术前10min首次静注咪达唑仑0 2mg·kg、氯胺酮2mg·kg ,随后两组以微量注射泵输注控制在P·K组丙泊酚6 6 . 6 6 μg·kg-1·min-1和氯胺酮4 1 .6 6 μg·Kg-1·min-1。记录注药后5、10min、切痂、取皮、植皮及停药后5、10min各时段无创血压(MAP)心率(HR)脉搏氧饱和度(SpO2 )及两组氯胺酮用药量变化。结果:P·K组氯胺酮用药量比M·K组少,P·K组MAP和HR无明显变化(P >0 . 0 5 ) ,M·K组MAP、HR均较麻醉前升高(P <0 . 0 1) ,两组SpO2 于诱导注药后均有一过性下降,数分钟恢复正常,两组比较差异无显著意义(P >0 . 0 5 )。结论:微量注射泵输注丙泊酚和氯胺酮全凭静脉麻醉安全可行,副作用小,可控性强,适用于烧伤患者切痂植皮手术。 相似文献
6.
7.
目的 探讨咪达唑仑对剖宫产手术产妇情绪和记忆的影响.方法 72例择期剖宫产术产妇随机分成4组,Ⅰ、Ⅱ和Ⅲ组麻醉前30 min分别肌注咪达唑仑0.05、0.06和0.07 mg/kg,Ⅳ组肌注生理盐水1.5 ml,同时肌肉注射阿托品0.01 mg/kg.于注药前和注药后30 min进行焦虑视觉类比试验(AVAT)、状态焦虑问卷(SAI)测试及Ramsay镇静水平评估.将麻醉准备到手术结束过程分为5阶段,每项告知产妇,记录剖宫产术后4 h产妇能准确回忆的项目.结果 注药后30 min时,Ⅰ~Ⅲ组AVAT分别下降36.4%、43.2%和43.1%;SAI分别下降20.9%、24.8%和26.9%,均获得Ramsay 2~4级镇静水平.Ⅰ~Ⅲ组和Ⅳ组比较记忆保留组间差异均有统计学意义(P均<0.01).Ⅰ~Ⅲ组以遗忘静脉穿刺过程的居多,4组产妇对椎管内麻醉穿刺和新生儿娩出后性别识别两过程全部记忆完觋整.结论 剖宫产手术前给予咪达唑仑0.05~0.07 mg/kg,对产妇有良好的镇静和抗焦虑作用,对外显记忆有一定程度的影响,其中对信息量小和关注程度低的信息能产生顺行性遗忘作用,能保留信息量大和关注程度高的信息的完整记忆. 相似文献
8.
The inferior colliculus is involved in conveying auditory information of an aversive nature to higher cortical structures.
Gradual increases in the electrical stimulation of this structure produce progressive aversive responses from vigilance, through
freezing, until escape. Recently, we have shown that microinjections of NMDA into the inferior colliculus mimic these aversive
effects and that the neural substrates responsible for learned escape behavior in the inferior colliculus are regulated by
GABA−benzodiazepine mechanisms. In the present study, we extend these observations showing that unlearned aversive responses
are also depressed by muscimol and midazolam, both GABA-benzodiazepine agonists, and that microinjection of glutamate, an
excitatory amino acid, into the inferior colliculus can trigger freezing responses. Electrical stimulation of the inferior
colliculus of rats placed inside an open field allowed the determination of thresholds for the aversive responses, alertness,
freezing and escape. Systemic administration (3 and 5.6 mg/kg) as well as microinjections into the inferior colliculus of
the anxiolytic compound midazolam (10, 20 and 40 nmol) caused increases in threshold for these aversive responses. Similar
results were obtained following microinjections of the GABA-A agonist muscimol (0.1, 1 and 5 nmol) into this brainstem structure.
Microinjections of low doses of glutamate (5 nmol), presumed to activate mainly AMPA/kainate receptors, into the ventrolateral
division of the central nucleus of the inferior colliculus of rats placed inside a circular arena induced aversive reactions,
characterized by freezing responses. However, higher doses of glutamate caused no apparent effects. GDEE, an AMPA/kainate
receptor antagonist, inhibited, whereas AP7, a NMDA receptor antagonist, did not influence these responses. It is suggested
that GABA-benzodiazepine processes modulate the expression of defensive reactions in the inferior colliculus and that activation
of fast-acting excitatory amino acid receptors in this midbrain region can trigger the initial steps of the defense reaction
without eliciting the motor explosive behavior usually seen following the activation of NMDA receptors.
Received: 13 May 1998 / Final version: 12 August 1998 相似文献
9.
Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit 总被引:1,自引:0,他引:1
Twenty-four patients in a paediatric intensive care unit mostly undergoing cardiac surgery, received a midazolam dosage between 50–400 g/kg per hour as a continuous intravenous infusion partly in combination with fentanyl [0,5–2,5 g/kg per hour] for analgesia and sedation. The mean duration of midazolam infusion was 11.6 days (range 38h–40 days). Blood samples for the HPLC assay of serum midazolam concentration were taken and the clearance estimated. The efficiency of sedation in correlation to the midazolam concentration was evaluated by a clinical sedation score. Serum midazolam concentrations between 100–400 g/l were sufficient for sedation. Dosage had to be increased during therapy according to an increased midazolam clearance. The evaluation of the sedation score showed that sedation of artifically ventilated infants and young children can be established by continuous intravenous infusion of midazolam.Dedicated to the 65th birthday of Prof.Dr. Erich Gladtke 相似文献
10.
Benzodiazepines have been reported to induce eating when administered into the brainstem of rats (either the fourth ventricle or the parabrachial nucleus). Benzodiazepines in the brainstem also have been reported to enhance the hedonic impact of taste, as measured by hedonic/aversive taste reactivity patterns, when administered to the fourth ventricle. The present study examined whether the parabrachial nucleus in particular is a brainstem site of the benzodiazepine-produced enhancement of eating and palatability. Food intake (cereal mash) was measured after brainstem microinjections of midazolam or vehicle (0.0, 7.5, and 15.0 microg) into the parabrachial nucleus, the nucleus of the solitary tract, the pedunculopontine tegmental nucleus, or the fourth ventricle (60 microg). We used the taste reactivity paradigm to measure hedonic/aversive affective reactions elicited from rats by oral infusions of a bittersweet solution (7% sucrose-0.01% quinine). Positive hedonic reactions and negative aversive reactions to sucrose-quinine were also measured after microinjections of midazolam (0.0, 7.5, and 15 microg) into the parabrachial nucleus. Midazolam increased food intake and selectively enhanced positive hedonic taste reactivity patterns to the bittersweet solution when microinjections were delivered to the parabrachial nucleus. When administered to the other brainstem sites at the same doses, however, midazolam had no effect. We therefore conclude that the parabrachial nucleus can mediate the benzodiazepine-induced enhancement of the hedonic impact of taste as well as mediating the enhancement of eating behavior. 相似文献